-
-
-
-
-
-
-
Arrowhead Pharmaceuticals Reports Fiscal 2023 Third Quarter Results
-
-
-
-
-
-
-
'Uncertain times ahead': GlaxoSmithKline (GSK) stock falls 4% as UBS moves to Sell
-
-
-
-
-
-
-
U.S. CPI, Saudi Pushback, Earnings Season Ramp-Up - What's Moving Markets
-
-
-
-
-
-
-
GSK (GSK) announces update on proposed demerger of the Consumer Healthcare business to form Haleon
-
-
-
-
-
-
-
GlaxoSmithKline (GSK) Earnings Preview - Credit Suisse
-
-
-
-
-
-
-
U.S. pharmacies attract new flu shot customers as coronavirus surges
-
-
-
-
-
-
-
Biopharma Leaders Unite to Stand with Science
-
975,813 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All